Clinical Trial Update: A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy. [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating a Pfizer experimental gene therapy for Duchenne Muscular Dystrophy has been terminated. The trial aimed to assess long-term safety an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Experimental Gene Therapy

Snippet

Sponsor: Pfizer | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: TERMINATED